XJPX
9776
Market cap42mUSD
Dec 05, Last price
1,962.00JPY
1D
-0.15%
1Q
80.66%
Jan 2017
67.12%
Name
Sapporo Clinical Laboratory Inc
Chart & Performance
P/E
14.08
P/S
0.32
EPS
139.37
Div Yield, %
1.17%
Shrs. gr., 5y
-1.78%
Rev. gr., 5y
2.66%
Revenues
20.13b
+2.28%
Net income
464m
+22.10%
CFO
731m
-32.17%
Dividend
Mar 30, 202623 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Sapporo Clinical Laboratory Inc. operates dispensing pharmacies in Japan. The company offers clinical examination, pathological examination, and holter examination services. It provides food hygiene environmental inspection, including food/processed product, facility hygiene, and food handler inspection services; and radiation management services. In addition, the company develops, sells, and maintains software, such as SCAN clinical testing systems; and offers support services for opening new clinics. Further, it provides HiWeb21 inspection result inquiry services, as well as sells and maintains software relating to clinical testing. The company was incorporated in 1965 and is based in Sapporo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||